Stereotactic ablative radiotherapy for bone metastasis of gastrointestinal stromal tumor: Case report and review of the literature.

Autor: Yilmaz MT; Hacettepe University Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey., Gultekin M; Hacettepe University Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey., Yalcin S; Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey., Tuncel M; Hacettepe University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey., Gedikoglu G; Hacettepe University Faculty of Medicine, Department of Pathology, Ankara, Turkey., Yildiz F; Hacettepe University Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey., Cengiz M; Hacettepe University Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey.
Jazyk: angličtina
Zdroj: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology [Rep Pract Oncol Radiother] 2020 May-Jun; Vol. 25 (3), pp. 331-335. Date of Electronic Publication: 2020 Feb 24.
DOI: 10.1016/j.rpor.2020.02.013
Abstrakt: Background: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. These tumors are rare and only make bone metastases at a rate of 5%.
Case Summary: A 31-year-old male with a GIST presented with solitary bone metastasis at the right iliac bone. We performed stereotactic ablative radiotherapy (SABR) and achieved excellent local control. Herein, our case is presented, and a short review of the literature is carried out.
Conclusion: SABR should be considered as a treatment option in GIST with bone metastasis.
(© 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.)
Databáze: MEDLINE